Is QuilliChew ER a controlled substance?
Medically reviewed by Drugs.com Last updated on Apr 12, 2019.
Official Answerby Drugs.com
Yes, QuilliChew ER (methylphenidate HCl) is schedule II controlled substance, meaning it has a high potential for abuse.
QuilliChew ER is a central nervous system (CNS) stimulant that contains methylphenidate, which is a commonly used medication for attention deficit hyperactivity disorder (ADHD). QuilliChew ER is available only by prescription from your doctor.
Pfizer currently manufactures two different methylphenidate products for the treatment of attention deficit hyperactivity disorder (ADHD) in patients 6 years old and above – liquid Quillivant XR and QuilliChew ER chewable tablets.
Related Medical Questions
- Ritalin vs Vyvanse - What's the difference between them?
- Concerta vs Adderall. What is the difference between them?
- How is Cotempla XR-ODT different to other brands of methylphenidate?
- What is the difference between Jornay PM and other once-daily methylphenidate formulations?
- What are the brands of methylphenidate?
- QuilliChew ER Information for Consumers
- QuilliChew ER Information for Healthcare Professionals (includes dosage details)
- Side Effects of QuilliChew ER (detailed)